Article
Triangulating evidence from longitudinal and Mendelian randomization studies of metabolomic biomarkers for type 2 diabetes.
Scientific reports - 18 Mar 2021
Porcu Eleonora, Gilardi Federica, Darrous Liza, Yengo Loic, Bararpour Nasim, Gasser Marie, Marques-Vidal Pedro, Froguel Philippe, Waeber Gerard, Thomas Aurelien, Kutalik Zoltán
Abstract excerpt
The number of people affected by Type 2 diabetes mellitus (T2DM) is close to half a billion and is on a sharp rise, representing a major and growing public health burden. Given its mild initial symptoms, T2DM is often diagnosed several years after its onset, leaving half of diabetic individuals undiagnosed. While several classical clinical and genetic biomarkers have been identified, improving early diagnosis by...
Topics
Join the communities discussing this publication.